Actively Recruiting
Role of the Immune System in Preventing Laryngeal Cancer
Led by European Institute of Oncology · Updated on 2026-04-02
3
Participants Needed
1
Research Sites
58 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Laryngeal dysplasia and progression to carcinoma: investigating genetic and immune alterations predictive of malignant transformation
CONDITIONS
Official Title
Role of the Immune System in Preventing Laryngeal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histopathological diagnosis of laryngeal dysplasia
- Age over 18 years
- Provided informed consent to participate in the research
You will not qualify if you...
- Prior surgical, radiotherapy, or cancer treatments to head and neck regions
- Congenital or acquired immunodeficiency disorders
- Having other simultaneous cancers
- Receiving immunosuppressive therapy
- Under 18 years of age or lack of research consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
European Institute of Oncology
Milan, MI, Italy, 20141
Actively Recruiting
Research Team
M
Marta Tagliabue, MD
CONTACT
F
francesca lombardi
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here